Leelawat K, Narong S, Udomchaiprasertkul W, Wannaprasert J, Treepongkaruna SA, Subwongcharoen S, Ratanashu-ek T. Prognostic relevance of circulating CK19 mRNA in advanced malignant biliary tract diseases. World J Gastroenterol 2012; 18(2): 175-181 [PMID: 22253524 DOI: 10.3748/wjg.v18.i2.175]
Corresponding Author of This Article
Dr. Kawin Leelawat, Department of Surgery, Rajavithi Hospital, Bangkok 10400, Thailand. firstname.lastname@example.org
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Quantitative variables are presented as the mean value, with the exception of cancer antigen (CA)19-9 and carcinoembryonic antigen (CEA), which are presented as median values.
1Pearson χ2 was used to compare two groups;
2Mann-Whitney U test was used to compare groups. CK19: Cytokeratin 19; hTERT: Human telomerase reverse transcriptase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; BUN: Blood urea nitrogen.
Table 4 Survival analysis using clinical parameters measured by univariable and multivariable analysis